These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 21677915
1. Diagnosis in diabetes: does it matter? Thethy I, Robertson L, Swaminathan K. J R Coll Physicians Edinb; 2011 Jun; 41(2):119-21. PubMed ID: 21677915 [Abstract] [Full Text] [Related]
2. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Ellard S, Colclough K. Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892 [Abstract] [Full Text] [Related]
3. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults. Fendler W, Borowiec M, Antosik K, Szadkowska A, Deja G, Jarosz-Chobot P, Mysliwiec M, Wyka K, Pietrzak I, Skupien J, Malecki MT, Mlynarski W. Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320 [Abstract] [Full Text] [Related]
4. When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management. Juszczak A, Pryse R, Schuman A, Owen KR. Br J Gen Pract; 2016 Jun; 66(647):e457-9. PubMed ID: 27231307 [No Abstract] [Full Text] [Related]
5. Who should have genetic testing for maturity-onset diabetes of the young? Naylor R, Philipson LH. Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318 [Abstract] [Full Text] [Related]
6. Three novel mutations in MODY and its phenotype in three different Czech families. Bazalová Z, Rypácková B, Broz J, Brunerová L, Polák J, Rusavý Z, Treslová L, Andel M. Diabetes Res Clin Pract; 2010 May; 88(2):132-8. PubMed ID: 20132997 [Abstract] [Full Text] [Related]
7. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Owen K, Hattersley AT. Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773 [Abstract] [Full Text] [Related]
8. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Ellard S. Hum Mutat; 2000 Nov; 16(5):377-85. PubMed ID: 11058894 [Abstract] [Full Text] [Related]
9. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW, DPV-Wiss Initiative of the German Working Group for Paediatric Diabetology and. Diabet Med; 2009 May; 26(5):466-73. PubMed ID: 19646184 [Abstract] [Full Text] [Related]
10. Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families. Domínguez-López A, Miliar-García A, Segura-Kato YX, Riba L, Esparza-López R, Ramírez-Jiménez S, Rodríguez-Torres M, Canizales-Quinteros S, Cabrera-Vásquez S, Fragoso-Ontiveros V, Aguilar-Salinas CA, Altamirano-Bustamante N, Calzada-León R, Robles-Valdés C, Bravo-Ríos LE, Tusié-Luna MT. JOP; 2005 May 10; 6(3):238-45. PubMed ID: 15883474 [Abstract] [Full Text] [Related]
11. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY). Toaima D, Näke A, Wendenburg J, Praedicow K, Rohayem J, Engel K, Galler A, Gahr M, Lee-Kirsch MA. Hum Mutat; 2005 May 10; 25(5):503-4. PubMed ID: 15841481 [Abstract] [Full Text] [Related]
12. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Estalella I, Rica I, Perez de Nanclares G, Bilbao JR, Vazquez JA, San Pedro JI, Busturia MA, Castaño L, Spanish MODY Group. Clin Endocrinol (Oxf); 2007 Oct 10; 67(4):538-46. PubMed ID: 17573900 [Abstract] [Full Text] [Related]
13. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Stride A, Hattersley AT. Ann Med; 2002 Oct 10; 34(3):207-16. PubMed ID: 12173691 [Abstract] [Full Text] [Related]
16. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Hattersley AT. Diabet Med; 1998 Jan 10; 15(1):15-24. PubMed ID: 9472859 [Abstract] [Full Text] [Related]
17. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Xu JY, Dan QH, Chan V, Wat NM, Tam S, Tiu SC, Lee KF, Siu SC, Tsang MW, Fung LM, Chan KW, Lam KS. Eur J Hum Genet; 2005 Apr 10; 13(4):422-7. PubMed ID: 15657605 [Abstract] [Full Text] [Related]
18. [MODY, a model of genotype/phenotype interactions in type 2 diabetes]. Velho G, Bellanné-Chantelot C, Timsit J. Med Sci (Paris); 2003 Apr 10; 19(8-9):854-9. PubMed ID: 14593617 [Abstract] [Full Text] [Related]
19. Glucokinase mutations in young children with hyperglycemia. Codner E, Deng L, Pérez-Bravo F, Román R, Lanzano P, Cassorla F, Chung WK. Diabetes Metab Res Rev; 2006 Apr 10; 22(5):348-55. PubMed ID: 16444761 [Abstract] [Full Text] [Related]
20. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Cao H, Shorey S, Robinson J, Metzger DL, Stewart L, Cummings E, Hegele RA. Hum Mutat; 2002 Dec 10; 20(6):478-9. PubMed ID: 12442280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]